SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
Saved in:
| Title: | SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis. |
|---|---|
| Authors: | Zhao W; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Wang X; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA.; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Han L; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Zhang C; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China., Wang C; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Kong D; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China., Zhang M; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Xu T; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Li G; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Hu G; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Luo J; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Stahl A; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA., Chen X; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. xinchen3@hawaii.edu.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. xinchen3@hawaii.edu., Zhang Y; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. youcai.zhang@tju.edu.cn. |
| Source: | Nature communications [Nat Commun] 2024 Aug 30; Vol. 15 (1), pp. 7522. Date of Electronic Publication: 2024 Aug 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
